Navigation Links
GlaxoSmithKline Obtains Exclusive U.S. OTC Marketing Rights to MEVACOR(R) (lovastatin) from Merck & Co., Inc.
Date:11/26/2007

his endpoint, significant slowing of disease was seen, with regression in 23% of patients treated with lovastatin compared to 11% of placebo patients.

In the Familial Atherosclerosis Treatment Study (FATS), either lovastatin or niacin in combination with a bile acid sequestrant for 2.5 years in hyperlipidemic subjects significantly reduced the frequency of progression and increased the frequency of regression of coronary atherosclerotic lesions by QCA compared to diet and, in some cases, low-dose resin.

The effect of lovastatin on the progression of atherosclerosis in the coronary arteries has been corroborated by similar findings in another vasculature. In the Asymptomatic Carotid Artery Progression Study (ACAPS), the effect of therapy with lovastatin on carotid atherosclerosis was assessed by B-mode ultrasonography in hyperlipidemic patients with early carotid lesions and without known coronary heart disease at baseline. In this double-blind, controlled clinical trial, 919 patients were randomized in a 2 x 2 factorial design to placebo, lovastatin 10-40 mg daily and/or warfarin. Ultrasonograms of the carotid walls were used to determine the change per patient from baseline to three years in mean maximum intimal-medial thickness (IMT) of 12 measured segments. There was a significant regression of carotid lesions in patients receiving lovastatin alone compared to those receiving placebo alone (p=0.001). The predictive value of changes in IMT for stroke has not yet been established. In the lovastatin group there was a significant reduction in the number of patients with major cardiovascular events relative to the placebo group (5 vs. 14) and a significant reduction in all-cause mortality (1 vs. 8).

Eye

There was a high prevalence of baseline lenticular opacities in the patient population included in the early clinical trials with lovastatin. During these trials the appearance of new opacities was noted in both the lovastatin and placebo gr
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related medicine news :

1. GlaxoSmithKline Responds to JAMA Articles
2. MedImmune Licenses Reverse Genetics Technology to GlaxoSmithKline for Use in Influenza Vaccine Development and Production
3. Congressional Black Caucus Foundation and GlaxoSmithKline Announce Supplier Business Initiative Study Results
4. AUDIO from Medialink and GlaxoSmithKline: A New Nasal Spray for Allergy Relief
5. Mylan Announces Settlement of Paroxetine Hydrochloride Extended-Release Tablets with GlaxoSmithKline
6. GlaxoSmithKline Aids California Fire Relief Efforts
7. Genmab and GlaxoSmithKline Initiate Ofatumumab Rheumatoid Arthritis Phase III Program
8. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
9. Southwest Ambulance Awarded Exclusive, 3-Year Contract Extension in Peoria, Arizona
10. Crdentias VP of Marketing, Christina Hogan, Provides Exclusive Interview on Marketing Strategy
11. Pearson VUE Signs Exclusive Contract with Educational Resources, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... HealthDay Reporter WEDNESDAY, Aug. 20, 2014 ... group of rhesus monkeys from deadly Marburg virus, a very ... percent of those it infects, researchers report. The drug ... even when it was given three days after infection, according ... Science Translational Medicine . This is the first drug ...
(Date:8/20/2014)... have discovered that the immune system is defective in people ... why sufferers have ongoing issues with pain. , The research ... could also help to explain why some painkillers may not ... affects up to 10% of the community. There are ... gut pain, which often has the greatest impact on sufferers, ...
(Date:8/20/2014)... 2014 Hundreds of Mirena IUD lawsuits ... who were allegedly injured due to spontaneous migration of ... Bergen County Superior Court, Bernstein Liebhard LLP reports. According ... 2014, the Court has established procedures regarding the production ... are part of the proceeding’s initial disposition pool. (In ...
(Date:8/20/2014)... 20, 2014 (HealthDay News) -- Loss of brain cells ... why many seniors have trouble falling and staying asleep, ... disruption can be especially severe and often results in ... The investigators analyzed data from the Rush Memory and ... at age 65 and are being followed until death, ...
(Date:8/20/2014)... Kathleen Doheny HealthDay Reporter ... a mastectomy has long been an option, but a new ... it. "The most common reasons women didn,t undergo reconstruction ... in more surgery or they were focused on their cancer ... surgery at Memorial Sloan Kettering Cancer Center, in New York ...
Breaking Medicine News(10 mins):Health News:Drug for Ebola-Like Virus Shows Promise in Monkeys 2Health News:Drug for Ebola-Like Virus Shows Promise in Monkeys 3Health News:Pain treatments less effective for those with irritable bowel 2Health News:Mirena Lawsuit News: Case Management Order Issued in New Jersey Mirena Litigation, Bernstein Liebhard LLP Reports 2Health News:Mirena Lawsuit News: Case Management Order Issued in New Jersey Mirena Litigation, Bernstein Liebhard LLP Reports 3Health News:Mirena Lawsuit News: Case Management Order Issued in New Jersey Mirena Litigation, Bernstein Liebhard LLP Reports 4Health News:Seniors' Sleep Woes May Be Linked to Loss of Brain Cells 2Health News:Many Women Who Have Mastectomy Don't Get Breast Reconstruction: Study 2Health News:Many Women Who Have Mastectomy Don't Get Breast Reconstruction: Study 3
... studies published in the May issue of the journal ... the staggering economic impact of toxic chemicals and air pollutants ... of new chemicals and also those already on the market. ... and Pediatrics at Mount Sinai School of Medicine, analyzed the ...
... Salamon HealthDay Reporter , WEDNESDAY, May 4 (HealthDay ... concussion while playing sports should immediately pull players off the ... -- to avoid a potentially permanent brain injury, according to ... on youth sports injury prevention held by Safe Kids USA, ...
... and HIV (K-RITH) has awarded a total of 1.7 ... and students to help build new tuberculosis and HIV ... first Collaborative Grants awarded by K-RITH, which was founded ... KwaZulu-Natal (UKZN) and the Howard Hughes Medical Institute (HHMI). ...
... who received therapy for cancer during childhood have ... later in life, according to a new study ... the American Gastroenterological Association (AGA) Institute. Compared with ... of late-onset complications of the upper GI tract, ...
... , WEDNESDAY, May 4 (HealthDay News) -- Adults ... but simply asking teens about their wishes and hopes revealed ... adolescents, aged 11 to 18, who completed a health screening ... wishes, what would they be?" The researchers found that ...
... address the often-overlooked costs associated with atrial fibrillation (AFib), ... study evaluates these costs and updates a growing body ... are complex and may not yet be fully understood. ... ATHENA trial, a placebo-controlled, double-blind, parallel arm trial to ...
Cached Medicine News:Health News:Estimated costs of environmental disease in children at $76.6 billion per year 2Health News:Estimated costs of environmental disease in children at $76.6 billion per year 3Health News:Football Legend Steve Young Urges Kids, Parents to Play It Safe 2Health News:Football Legend Steve Young Urges Kids, Parents to Play It Safe 3Health News:K-RITH awards grants to foster teamwork among South African TB/HIV scientists 2Health News:Childhood cancer survivors are at increased risk for ongoing post-therapy GI complications 2Health News:Simple Question Sheds Light on Teens' Hopes, Dreams 2Health News:Data evaluates rehospitalization and cost burden of AFib/atrial flutter 2
(Date:8/20/2014)... , Aug. 20, 2014   Ventana ... Roche  Group, today announced that its VENTANA System ... marked in the European Union for routine pathology, ... system, consisting of VENTANA Virtuoso software coupled with ... iScan HT slide scanner, provides automated digital slide ...
(Date:8/20/2014)... ARBOR, Mich. and PHOENIX ... non-profit corporation established to bring cutting-edge next-generation sequencing ... to cancer patients, today announced a collaboration with ... capabilities to characterize patient tissue samples from clinical ... sensitive or resistant to TESARO,s TSR-011.  This may lead ...
(Date:8/20/2014)... NEW YORK , Aug. 20, 2014 ... available in its catalogue: Global Feminine Hygiene ... This report analyzes the worldwide markets for Feminine ... Segments: Sanitary Pads/Towels, Tampons, Panty liners, and Others. The ... Canada , Japan , ...
Breaking Medicine Technology:Full digitization of the anatomic pathology lab is here with the VENTANA System for Primary Diagnosis 2Full digitization of the anatomic pathology lab is here with the VENTANA System for Primary Diagnosis 3Paradigm Announces Molecular Profiling Collaboration with TESARO, Inc. 2Global Feminine Hygiene Products Industry 2Global Feminine Hygiene Products Industry 3Global Feminine Hygiene Products Industry 4Global Feminine Hygiene Products Industry 5Global Feminine Hygiene Products Industry 6Global Feminine Hygiene Products Industry 7Global Feminine Hygiene Products Industry 8Global Feminine Hygiene Products Industry 9Global Feminine Hygiene Products Industry 10Global Feminine Hygiene Products Industry 11Global Feminine Hygiene Products Industry 12Global Feminine Hygiene Products Industry 13Global Feminine Hygiene Products Industry 14Global Feminine Hygiene Products Industry 15Global Feminine Hygiene Products Industry 16Global Feminine Hygiene Products Industry 17Global Feminine Hygiene Products Industry 18Global Feminine Hygiene Products Industry 19Global Feminine Hygiene Products Industry 20Global Feminine Hygiene Products Industry 21Global Feminine Hygiene Products Industry 22Global Feminine Hygiene Products Industry 23Global Feminine Hygiene Products Industry 24Global Feminine Hygiene Products Industry 25Global Feminine Hygiene Products Industry 26
... Ltd. (Sun) (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, ... Israel has unanimously dismissed the appeal by Taro Pharmaceutical ... of the previous ruling by the Tel-Aviv District Court ... do not apply to the Tender Offer by Sun,s ...
... Havel,s Incorporated, the Cincinnati-based market leader in echogenic ... echogenic ultrasound needle which could help reduce radiation ... echogenic needles using their new, innovative Micro Laser ... to reflect sound waves back to the transducer ...
Cached Medicine Technology:Supreme Court of Israel Rules in Favor of Sun Pharma 2Supreme Court of Israel Rules in Favor of Sun Pharma 3Havel's Incorporated Helping to Reduce Radiation Exposure with New EchoTuohy™ Ultrasound Needle 2
For primary and revision cases...
The Protract stem offers a press-fit option which will allow choice of standard or lateralized neck offsets while keeping a consistent leg length....
Standard Erlanger hip stem....
Cemented foundation 460 series....
Medicine Products: